







































Werner syndrome (WS) is a rare autosomal disease 
characterised by multiple progeroid features like 
graying and loss of hair, development of diabetes, 
cataracts, osteoporosis, and cardiovascular disorders at 
an early age [1]. At the cellular level, WS fibroblasts 
derived from patients exhibit genomic instability 
demonstrated by many chromosomal rearrangements, 
recombination defects, and accumulation of oxidative 
damage [2-6]. Furthermore, WS fibroblasts reach 
senescence prematurely in culture compared to age-
matched normal fibroblasts [7, 8]. The gene responsible 
for WS (WRN) was identified by positional cloning and 









































the RecQ-type DNA helicases [9]. The protein also 
possesses a 3’-5’ exonuclease activity in addition to its 
3’-5’ helicase activity [10, 11]. Accumulating evidences 
indicate that WRN protein is involved in DNA 
replication/repair, telomere maintenance, and 
transcription as well [3, 12-17]. Finally, the WRN 
protein regulates chromatin structures in concert with 
topoisomerase I to guard against DNA breaks and 
genomic instability [18]. 
 
The Scaffold attachment factor 1 (SAFB1) is also 
believed to be closely involved in higher order 
chromatin structure and in the partitioning of chromatin 
into distinct topologically independent loops [19, 20]. 
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protein interactions regions and a SAF-Box, which is a 
homeodomain-like DNA-binding motif that interacts 
with AT-rich scaffold-matrix attachment regions 
(S/MARs) [22, 23]. S/MARs mediate the attachment of 
chromatin to the nuclear matrix [23]. SAFB1 is also 
known to interact with many RNA processing proteins, 
participating in RNA splicing and the regulation of 
transcription during cellular stress response [24, 25]. 
Knockout mice lacking expression of the SABF1 
protein exhibit perinatal lethality [26]. More than half of 
the newborn Safb1-null mice display incomplete 
maturation of the alveoli in their lungs suggesting a 
dysfunctional oxygen exchange in these animals [26]. 
The surviving Safb1-null mice (approximately 11%) are 
smaller than heterozygous Safb1
+/- mice and are sterile 
[26]. Interestingly, mouse embryonic fibroblasts 
(MEFs) derived from Safb1-null embryos show lack of 
senescence and evidence of cell immortalization in 
culture [27].  
 
In this study, we examined the impact of a defective 
Wrn protein (helicase dead Wrn protein) on the 
phenotype of Safb1-null embryos in vivo and in cultured 
cells. We found increased perinatal death in double 
homozygous mutant mice concomitantly with 
significant apoptosis in the lungs of such animals. 
Lastly, we found lack of immortalization of Safb1-null 
MEFs in the absence of a functional Wrn helicase 




Interaction between WRN and SAFB1 in human cells 
 
Recent mass spectrometry analyses in our laboratory 
indicated a potential interaction between WRN and 
SAFB1 proteins [28]. To confirm this result, we 
immunoprecipitated the WRN protein from HEK 293 
cells and analyzed the immunoprecipitate with an 
antibody against SAFB1. As indicated in Figure 1, 
SAFB1 protein was co-immunoprecipitated with an 
antibody against the WRN protein but not with a control 
IgG. We were unable to immunoprecipitate the SAFB1 
protein with the commercial antibody used in this study 
(data not shown).  
 
Increased perinatal lethality in Safb1-null mice 
lacking a functional Wrn helicase  
 
To determine the impact of Wrn and Safb1 proteins on 
the health of mice, mutant animals expressing Wrn 
protein lacking part of the helicase domain (referred as 
Wrn
Δhel/Δhel hereafter) were crossed to Safb1-null mice. 
Progenies from the F1 and F2 generations were 
intercrossed to obtain all potential genotypes. Safb1-null 
mice are known to exhibit perinatal lethality [26]. As 
indicated in Table 1, crosses between Safb1
+/- 
heterozygous mice on a Wrn wild type background 
indicated that only 10% of weaned pups were Safb1
-/- 
homozygous (five males and nine females). This 
number is close to the 7% of Safb1
-/- homozygous live 
weaned pups originally described [26]. We also noted a 
diminution in the number of expected heterozygous 
animals (P < 0.0001). We then calculated the number of 
Safb1
-/-/Wrn
Δhel/Δhel double homozygous mutant live 
pups obtained at weaning. Table 1 indicated that only 
3% of weaned pups were Safb1
-/-/Wrn
Δhel/Δhel double 
homozygous mutant animals. The number of Safb1
+/-
/Wrn
Δhel/Δhel animals was higher than expected for an 
unknown reason. We genotyped several dead pups in 
the cages and found many Safb1
-/-/Wrn
Δhel/Δhel double 
homozygous mutants. However, since dead pups were 











Δhel/Δhel males and sacrificed pregnant 
dams at 19 days of gestation. Although we genotyped 
few in utero embryos, the number of Safb1
-/-/Wrn
Δhel/Δhel 
animals were close to the expected Mendelian ratio 
(Table 1). The distribution was not significantly 
different from the expected Mendelian distribution (P = 
0.2742). We conclude from these results that most 
Safb1
-/-/Wrn
Δhel/Δhel animals died at birth (P < 0.0001; 


























Figure  1.  Co‐immunoprecipitation  of  SAFB1  with  the  WRN 
protein in HEK 293 cells. Immunoprecipitation was performed 
with  an  antibody  against  the  WRN  protein.  The  immuno‐
precipitate  was  analyzed  by  western  blot  analyses  with  an 
antibody  against  SAFB1.  The  lysate  represents  10%  of  total 
proteins in the immunoprecipitation reaction.  
   






























Life span of Safb1
-/-/Wrn
Δhel/Δhel double homozygous 
animals 
 
As indicated in Table 1, only six Safb1
-/-/Wrn
Δhel/Δhel 
males (no female) survived weaning (P < 0.0001; 
significantly different from the expected Mendelian 
distribution). The reason for the absence of females is 
unknown as the sample size of Safb1
-/-/Wrn
Δhel/Δhel at 
weaning was very small (six animals only), but not 
smaller than Safb1-null mice (data not shown). Safb1-
null animals are smaller than age-matched wild type 
mice [26]. Two of the Safb1
-/-/Wrn
Δhel/Δhel males were 
sacrificed at two months of age to analyze the tissues. 
Apart from their small size and alopecia 
(Supplementary Figure 1), no gross abnormality was 
found in their tissues. The remaining four animals were 
kept alive in cages to determine their life span. As 
indicated in Table 2, Safb1
-/-/Wrn
Δhel/Δhel mice had to be 
euthanized because they had lost approximately 30% of 
their weight in one month and were moribund or 
immobile in the cage. Blood was found in the urine and 
several of these mice had infection in their eyes. 
Because of the small sample size, we were unable to 
determine the exact cause of weight loss in these 
animals. The oldest Safb1
-/-/Wrn































sacrificed at 21 weeks of age (ill before six months of 
age). In contrast, more than 66% of Safb1-null/Wrn
+/+ 
animals (six out of nine animals) were still alive by six 
months of age (data not shown) and more than 95% of 
Wrn
Δhel/Δhel mice were alive at six months of age [29]. 
33% of Safb1-null/Wrn
+/+ animals had to be euthanized 
because they had lost more than 25% of their weight in 
one month and were moribund by six month of age. The 
phenotype spectrum included myeloid leukemia, blood 
in urine, infection of eyes, a lung tumor, a tumor in 
colon, or a tumor in muscle tissue (data not shown). The 
oldest Safb1-null animals died at the age of 21 months 
(due to an enlarged spleen and a tumor mass in fat 
tissue).  
 
Increased apoptosis and decreased cell proliferation 




The major phenotype of Safb1-null dying pups is the 
incomplete maturation of the alveoli in the lungs [26]. 
As indicated in Figure 2, the interalveolar septa of 
Safb1-null pups were larger than those observed in wild 
type animals. The lack of a functional Wrn helicase 
caused a decrease in the thickness of the interalveolar 








Number of animals  Genotypes 
+/+        +/-      -/- 
Ratio 





+/+ background      
Adults; 138  47          77         14  1 : 1.6 : 0.3  0.0001479 
Mutant Wrn
Δhel/Δhel 
 background      
Adults; 225  62         157          6  1 : 2.8 : 1.6  2.006e-14 
Embryos







Age of diseased animals  Comments 
10 weeks  Harderian gland hyperplasia left eye, alopecia 
11 weeks  30% loss in weight in one month, infection in one eye, lordokyphosis, 
moribund, alopecia 
15 weeks  25% loss in weight in one month, infection in both eyes 
21 weeks  30% loss in weight in one month, blood found in urine 
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quantification of the lung phenotype, we first examined 
the level of apoptosis in lung tissues using a TUNEL 
apoptosis kit. TUNEL assays were performed on the 
lungs of 19 days old embryos. The number of apoptotic 
cells was estimated on lung sections of three embryos 
for each genotype (Figure 3A). This number was nearly 
16-fold higher in Safb1-null/Wrn
Δhel/Δhel lung samples 
than in wild type and Safb1-null samples (unpaired 
student  t-test  P-value < 0.05 compared to wild type 
Wrn
+/+/Safb1
+/+ embryos) (Figure 3B). The number of 
apoptotic cells in the lungs of 19 days old Wrn
Δhel/Δhel 
embryos was approximately three-fold higher than in 
the lungs of wild type animals (Figure 3B). There was 
no significant increase in apoptotic figures in the lungs 
of  Safb1-null mice compared to wild type animals. 
These results indicate that there was more cell death in 
the lungs of Safb1
-/-/Wrn
Δhel/Δhel embryos at birth than 
the other genotypes. Cell death was homogeneously 
































Cell proliferation was also examined in the lungs of 19 
days old embryos with an antibody against the 
proliferation cell nuclear antigen (PCNA). As indicate 
in Figure 4, the number of PCNA positive stained cells 
in the lungs of Safb1-null mice was 27% greater than in 
the lungs of wild type animals (unpaired student t-test 
P-value < 0.001 compared to wild type Wrn
+/+/Safb1
+/+ 
embryos). In contrast, the number of PCNA positive 
cells in the lungs of Safb1
-/-/Wrn
Δhel/Δhel embryos was 
42% lower than wild type animals (unpaired student t-
test  P-value < 0.0001 compared to wild type 
Wrn
+/+/Safb1
+/+ embryos). These results indicate that a 
deficiency of SAFB1 increased pulmonary cell 
proliferation, but a deficiency in both Safb1 and Wrn 
functions significantly decreased cell proliferation and 
increase cell death in the lungs of mutant embryos. We 
conclude that the Wrn helicase is required for cell 













































19  days  old  embryos  from  the  indicated  genotypes.
Magnification 400X. 
 










Magnification  400X.  (B)  Average  number  of  apoptotic  figures  per
area of lung sections containing 1000 cells (n=3 embryos for each









































































Loss of Wrn helicase activity in Safb1-null mouse 
embryonic fibroblasts (MEFs) inhibits immorta-
lization 
 
The disruption of Safb1 activity in MEFs leads to cell 
immortalization in culture [27]. We determined the 
impact of Wrn regarding this process in MEFs 
established from Safb1-null embryos. Previous data 
have indicated that Wrn
Δhel/Δhel mutant MEFs acquire a 
slower growth rate than wild type MEFs with the 
number of passage in culture [30, 31]. MEFs from three 
to eight embryos of each genotype were established in 
six-well plates as described previously [32]. MEFs 
adhering and filling the wells were transferred onto 100-
mm petri dishes.  Once MEFs reached confluence, cells 
were trypsinized and transferred to two 100-mm petri 
dishes with fresh media. This was considered passage 
number one. Table 3 shows the maximum passage 
attained by the MEFs of each genotype in vitro. Wild 
type MEFS (from five embryos) were passaged 
approximately 18 times (approximately 36 population 
doublings) before they stopped dividing. Wrn
Δhel/Δhel 
MEFs (from three embryos) were passaged seven to ten 
times (14-20 population doublings) before entering 
crisis and stopped dividing in culture. All Safb1-null 
MEFs (three embryos) were passaged more than 40 
times (more than 80 population doublings) and were 
still growing rapidly in culture. MEFs established from 
Safb1
-/-/Wrn
Δhel/Δhel double homozygous mutant embryos 
(eight embryos) stopped dividing after the fifth or 
seventh passages.  
 
Because reduced growth rate is a property associated 
with Wrn
Δhel/Δhel MEFs [32], we examined this property 
in fibroblasts derived from Safb1
-/-/Wrn
Δhel/Δhel double 
homozygous mutant embryos. We thus measured the 
average growth rate of MEFs from three embryos of 
each genotype in culture (after seven to ten passages in 
culture) (Figure 5). The growth rate of Safb1-null MEFs 
was significantly greater than wild type MEFs (unpaired 
student  t-test  P-value < 0.000001) even after 24 
passages in  culture (Figure 5B).  The  calculated doubl- 
Table 3. Maximum number of passage for each mouse embryonic fibroblast genotype in vitro. 
 
Genotype  Number of passages  Comments 
Safb1
+/+/Wrn
+/+  18  Approximately 36 population doublings 
Safb1
+/+/Wrn
Δhel/Δhel  10  Approximately 20 population doublings 
Safb1
-/-/Wrn
+/+  no maximum  Still growing after 40 passages 
Safb1
-/-/Wrn







showing  a  major  decrease  in  cell  proliferation  in  Safb1‐
null/Wrn
∆hel/∆hel  embryos  compared  to  the  other  genotypes.
Magnification 400X. (B) Average number of apoptotic figures per
area  of  lung  sections  containing  1000  cells  (n=3  embryos  for
each  genotype)  (*:  unpaired  student  t‐test  P‐value  <  0.001
compared  to  wild  type  Safb1
+/+/Wrn
+/+  animals;  **:  unpaired

































ing time for Safb1-null and wild type cells were 34 and 
40 hours, respectively. Safb1-null MEFs also reached a 
higher density at confluence than wild type cells (Figure 
5A).  Wrn
Δhel/Δhel MEFs had a lower growth rate than 
wild type MEFs (unpaired student t-test  P-value < 
0.026). The calculated doubling time for Wrn
Δhel/Δhel 
MEFs was 43 hours. Finally, Safb1
-/-/Wrn
Δhel/Δhel double 
homozygous mutant cells did not grow after seven 
passages in culture and were detaching from the petri 
dishes (Figure 5A). All these results indicate that the 
Wrn helicase is required for the immortalization of 
Safb1-null MEFs in culture. 
 
Since the cell density at confluence between Safb1-null 
and wild type MEFs were different, we examined the 
cellular morphology of each genotype with a phase 
contrast microscopy (Figure 6). All the MEFs were 
examined after the fifth passage in culture. Wrn
Δhel/Δhel 
MEFs were much bigger and flatter than wild type cells 
(compare top and bottom left panels of Figure 6). Safb1-
null MEFs were smaller on average than wild type cells 
(top panels of Figure 6). Safb1
-/-/Wrn
Δhel/Δhel MEFs were 
bigger than Safb1-null cells but not as big as Wrn
Δhel/Δhel 
MEFs in culture. These preliminary microscopic 
observations suggest that cells lacking a functional Wrn 
helicase had the morphology of senescent cells in 
























































in  culture  (except  for  Safb1‐null  MEFs,  which  were  measured  at  passage  24).  Cells  (5  X  10




















∆hel/∆hel  MEFs  after  the  fifth  passage  in  culture. 
Magnification 600X. 
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induces senescence 
 
Replicative senescence of primary fibroblasts in vitro 
consists in the progressive loss of cell division abilities 
with cellular morphological changes and the 
accumulation of senescence-associated β-galactosidase 
activity [33]. We thus compared the number of 
senescence-associated β-galactosidase positive MEFs of 
each genotype after the fifth passage in culture. As seen 
in Figure 7A and B, loss of Wrn helicase activity 
strongly induced senescence-associated β-galactosidase 
activity in Safb1-null MEFs. The percentage of 
Wrn
Δhel/Δhel MEFs stained with the senescence-
associated  β-galactosidase was increased significantly 
by approximately 1.6-fold compared to wild type cells 
(unpaired student t-test; P  < 0.022). Finally, the 
percentage of Safb1
-/-/Wrn
Δhel/Δhel MEFs stained with the 
senescence-associated β-galactosidase was increased by 
three-fold compared to wild type cells (unpaired student 


































The disruption of Safb1 activity in mouse embryonic 
fibroblasts leads to the lack of p19Arf induction in 
culture [27]. The p19Arf protein is a known inducer of 
senescence in MEFs [34]. We thus examined the levels 
of several protein markers of senescence, namely p53, 
p21(Waf1), and p19Arf, as well a marker of cell 
proliferation (PCNA) in MEFs of each genotype (after 
at least the sixth passage in culture). The Western blots 
in Figure 8 show representative results. The p53 protein 
could be detected in wild type MEFs after a long 
exposure of Western blot, but we could not detect this 
protein in any mutant MEFs. The protein p21 was not 
detected in wild type cells and very weakly expressed in 
Safb1-null MEFs. It could be weakly detected in wild 
type cells only after a longer exposition of the Western 
blots (Supplementary Figure S2). It was expressed at 
high levels in Wrn
Δhel/Δhel MEFs. Although Safb1-
null/Wrn
Δhel/Δhel double homozygous mutant MEFs 
entered senescence more rapidly than Wrn
Δhel/Δhel MEFs, 
p21 expression was greatly reduced compared to 
Wrn
Δhel/Δhel cells. The p19Arf protein was detected only 
in wild type MEFs. Finally, PCNA proteins levels were 
concordant with the growth rates of each cell genotype. 
Its expression was the highest in Safb1-null MEFs and 
the lowest in Safb1-null/Wrn
Δhel/Δhel MEFs (Figure 8). 
These results indicate that the senescence of Safb1-
null/Wrn
Δhel/Δhel MEFs is a process independent of p53 
and p19Arf. 
 
Loss of both Wrn helicase and Safb1 activities has 
an additive effect on the appearance of DNA double 
strand breaks in MEFs  
 
As DNA damage can induce senescence in normal 
fibroblasts [35], we quantified the levels of DNA strand 
breaks in the MEFs (three embryos of each genotype) at 
passage 5 (after approximately 10 population doublings) 
by immunofluorescence with an antibody against γ-
H2AX, which marks double stranded DNA breaks [36]. 
As indicated in Figures 9A and B, the percentage of 
Safb1-null/Wrn
Δhel/Δhel MEFs with more than 20 γ-
H2AX foci reached almost 65% after five passage in 
vitro. Interestingly, even though Safb1-null MEFs were 
immortalizeed, such cells exhibited more γ-H2AX foci 
than wild type and Wrn
Δhel/Δhel MEFs. More than 25% of 
Wrn
Δhel/Δhel MEFs showed cells with more than 20 γ-
H2AX foci. In contrast, less than 15% of wild type 
MEFs had nuclei with more than 20 γ-H2AX foci. 
Approximately 80% of wild type MEFs had less than 10 
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Δhel/Δhel MEFs displayed more DNA 
damage on average than Safb1-null, Wrn









































The amount of DNA breaks/cell and the number 
senescent cells correlated with the levels of p38 
MAPK and PKCδ respectively, in double 
homozygous mutant MEFs 
 
We finally examined the levels of important kinases 
involved in cellular stress response and senescence. 
They include the p38 MAPK [35], the protein kinase C 
delta (PKCδ), and the Jun Kinase 1 (JNK1) [37, 38]. As 
shown in Figure 8, the levels of p38 increased in all 
mutant MEFs compared to wild type cells. High levels 
were found in Safb1-null and Safb1-null/Wrn
Δhel/Δhel 
MEFs with the highest signal in Safb1-null/Wrn
Δhel/Δhel 
MEFs (Figure 10A). An antibody against 
phosphorylated p38 gave a signal similar to total p38 in 
MEFs (data not shown). Total p38 levels correlated well 
with the amount of DNA damage observed in the 
different genotypic MEFs (Pearson’s correlation 
coefficient R





















































each  genotype  were  analyzed  by  immunoblotting  with
antibodies  against  the  indicated  proteins.  Proteins  were
extracted  from  wild  type,  Wrn




detected  by  immunofluorescence  with  an  antibody  against  γ‐
H2AX in MEFs of each genotype Magnification 600X. (B) Graph
representing  the  extent  of  double  stranded  breaks  detected
with an antibody against γ‐H2AX in MEFs of each genotype. The
percentage of cells with more than 0, 10, and 20 γ‐H2AX foci
were  computed  from  100  MEFs  established  from  three
independent  embryos  for  each  genotype  (total  of  300  cells
analyzed/genotype). Bars in the graph represent SEM. 
   
































The PKCδ level in Wrn
Δhel/Δhel MEFs was 2.6-fold 
higher than wild type cells (Figure 10C). It was 4.8-fold 
higher in Safb1-null/Wrn
Δhel/Δhel MEFs than in wild type 
cells. In contrast, PKCδ level in Safb1-null MEFs were 
4.9-fold lower than in wild type cells. Interestingly, the 
PKCδ protein levels correlated well with the percentage 
of senescent cells observed in the different genotypic 
MEFs (Pearson’s correlation coefficient R
2 > 0.98) 
(Figure 10D). 
 
JNK1 is known to be activated by increased PKCδ 
levels in cells [38]. We thus examine JNK1 levels in the 
different MEFs cultures. As indicated in Figure 8, JNK1 
was increased by ten-fold in both Wrn
Δhel/Δhel and Safb1-
null/Wrn
Δhel/Δhel cells. JNK1 level was increased by two-
fold in Safb1-null MEFs compared to wild type cells. 
This increase in Safb1-null MEFs, however, was not 
statistically significant (data not shown). JNK1 levels 
did not correlate with PKCδ levels, the amount of DNA 
damage, and the percentage of senescent cells in the 
different MEFs. JNK1 expression was significantly 
increased only in MEFs lacking Wrn helicase activity. 































SAFB1 was originally described as an S/MAR-binding 
protein important for chromatin organization in the 
nucleus [22, 23]. It is also involved in transcriptional 
repression of estrogen receptors [21] and in the 
formation of perichromatin granules near the nucleoli in 
response to heat shock [39]. At the physiological level, 
depletion of Safb1 activity in mice lead to 
developmental abnormalities in their lungs, high 
incidence of perinatal lethality, and dwarfism [26]. The 
WRN protein, in return, is involved in DNA 
replication/repair, telomere maintenance, and 
transcription as well [3, 12-17]. The WRN protein also 
regulates chromatin structures in concert with 
topoisomerase I to guard against DNA breaks and 
genomic instability [18]. Mice lacking part of the 
helicase domain of the murine Wrn gene [32] 
phenocopy the human WS since they exhibit 
dyslipidemia, type II diabetes, increased systemic 
reactive oxygen species, increased genomic DNA 
damage and a 16.5% reduced mean life span compared 
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potential interaction between WRN and SAFB1 protein 
in the context of intact chromatin [28]. Accordingly, we 
were able to co-immunoprecipitate the SAFB1 protein 
with antibodies against the WRN protein. We thus 
decided to cross Safb1-null mice with mice lacking part 
of the helicase domain of the Wrn protein to determine 
the impact of these proteins on the phenotype of Safb1-
null/Wrn
Δhel/Δhel mice at the physiological and cellular 
levels. Since WRN protein will affect the topology of 
the chromosomes [18] and SAFB1 is involved in 
chromatin organization [22, 23], we expected to see 
increased DNA damage in cells lacking the functions of 
both proteins with deleterious consequences on health 
span of mice, even though previous spectrometry 
analyses indicated that both proteins may not interact 
directly [28]. Indeed, we observed a greater perinatal 
lethality of the Safb1-null/Wrn
Δhel/Δhel pups compared to 
Safb1-null animals (on a normal Wrn
+/+ background). 
We generated 225 live mice at weaning by crossing 
Safb1
+/-/Wrn
Δhel/Δhel males and females. Only six males 
were genotyped double homozygous mutant Safb1
-/-
/Wrn
Δhel/Δhel at weaning. The reason for the absence of 
females is unknown as the sample size of Safb1-
null/Wrn
Δhel/Δhel at weaning is very small. We will 
require to generate an additional 1000 pups from such 
crosses to get enough live Safb1-null/Wrn
Δhel/Δhel mice at 
weaning and to obtain more significant statistical 
numbers. Despite the small size sample of Safb1-
null/Wrn
Δhel/Δhel males, it became obvious that such 
animals displayed a severe decreased life span. The 
oldest Safb1-null/Wrn
Δhel/Δhel mouse died at the age of 
21 weeks. This is in contrast to Safb1-null mice that can 
live up to 84 weeks. Wrn
Δhel/Δhel mice can live up to 100 
weeks [29]. All Safb1-null/Wrn
Δhel/Δhel males were 
smaller than wild type animals, had an infection of 
some sort, and displayed either alopecia or 
lordokiphosis. More importantly, these mice displayed 
severe weight loss before becoming completely 
moribund and immobile, at which point they had to be 
humanely euthanized. Immunohistochemistry analyses 
of pulmonary tissues indicated a significant decrease in 
cell proliferation (measured by counting the number of 
PCNA positive cells) and a significant increase in 
apoptotic figures in the same tissue of Safb1-
null/Wrn
Δhel/Δhel mice compared to all the other 
genotypes. Thus, the severe reduced life span and some 
of the premature aging like phenotypes observed in 
Safb1-null/Wrn
Δhel/Δhel mice could be explained by the 
increased apoptosis and reduced cell proliferation in 
several tissues like the lungs. Appropriate experiments 
are warranted to examine global expression profiling 
and the extent of apoptosis in several tissues of a bigger 
cohort of Safb1-null/Wrn
Δhel/Δhel From the results of this 
study, we infer that an increased apoptosis together with 
a reduction in cell proliferation are likely to affect 




An intact Wrn helicase is required for the 
immortalization of Safb1-null MEFs 
 
A major characteristic of Safb1-null MEFs is their 
immortal phenotype in vitro [27]. Here, we show for the 
first time that Safb1-null MEFs exhibit an increased 
number of double stranded breaks in vitro compared to 
wild type MEFs. Such increase in double stranded 
breaks may lead to mutations inactivating tumor 
suppressor genes or activating oncogenes. Accordinly, 
Safb1-null mice developed different tumors. 
Interestingly, the tumor suppressor p53, p19Arf, and 
p21Waf1 proteins were down regulated or absent in 
Safb1-null MEFs. The decreased expression of these 
proteins is likely implicated in the immortalized 
phenotype of Safb1-null MEFs. Loss of Wrn activity in 
Safb1-null MEFs, in return, totally inhibited 
immortalization and induced a senescence phenotype as 
shown by the increased percentage of Safb1-
null/Wrn
Δhel/Δhel stained with the senescence-associated 
β-galactosidase in culture. Wrn
Δhel/Δhel MEFs also 
showed a lack of p53 and p19Arf expressions. 
Wrn
Δhel/Δhel MEFs, however, displayed a major increase 
in p21Waf1 expression unlike Safb1-null MEFs. It is 
important to mention that p21 levels are elevated in 
prematurely senescent human fibroblasts from WS 
patients or Ku80-deficient mice aging prematurely [41, 
42]. The p21 protein is a potent cyclin-dependent kinase 
inhibitor that induces senescence of normal and tumor 
cells in vitro in a p53-independent manner [43, 44]. We 
found that Safb1-null/Wrn
Δhel/Δhel MEFs also displayed 
increased p21 protein expression in vitro compared to 
wild type and Safb1-null MEFs. This level, however, 
was not as high as in Wrn
Δhel/Δhel MEFs. We thus infer 
from these results that Safb1-null/Wrn
Δhel/Δhel cells 
lacking a functional Wrn helicase activity display a 
senescence phenotype in a p53- and p19Arf-
independent manner and that p21 may play a modest 
role during this process in Safb1 deficient cells. 
 
We recently reported that a depletion of WRN protein 
in human cells increase PKCδ activity in vitro [45]. In 
the present study, we found a significant increase in 
PKCδ protein levels in Wrn
Δhel/Δhel MEFs. This result is 
consistent with the increased PKCδ protein levels found 
in liver tissues of Wrn
Δhel/Δhel mice compared to wild 
type animals [29]. In addition, we found that PKCδ 
levels were higher in Safb1-null/Wrn
Δhel/Δhel cells. In 
contrast,  Safb1-null MEFs showed lower levels of 
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there was a near perfect correlation between PKCδ 
levels and the percentage of positive β-galactosidase 
stained cells depending on the genotype of the MEFs 
under study (Pearson’s correlation coefficient R
2 > 0.98 
in Figure 10D). This is a significant finding, as PKCδ 
plays a key role in the induction of senescence in human 
breast tumor cells and normal human diploid fibroblasts 
[37, 38, 46]. The very high levels of PKCδ in Safb1-
null/Wrn
Δhel/Δhel cells is independent of cellular DNA 
damage levels as Safb1-null MEFs have on average 
more double strand breaks than wild type and 
Wrn
Δhel/Δhel MEFs. In contrast, the p38 MAP Kinase 
correlated very well with the amount of DNA damage 
within each different MEF genotype (Pearson’s 
correlation coefficient R
2 > 0.95 in Figure 10B). This is 
consistent with the observation that p38 is activated in 
both a p53 dependent and independent manner after 
DNA damage [47]. Finally, JNK1 level was increased 
only in MEFs lacking the Wrn helicase activity and this 
independently of the Safb1 status in cells (Figure 8). 
These results suggest that the increased expression of 
PKCδplay a major role in the induction of senescence in 
MEFs. Additional studies are warranted to determine 
whether PKCδ inhibits immortalization of Safb1-null 
MEFs and what is the exact molecular mechanism 




Cell line.  Human 293 embryonic kidney cells were 
maintained in DMEM supplemented with 10% fetal 
bovine serum, penicillin (250 IU/mL), and 
Streptomycin (250 μl/mL) at 37°C in atmosphere of 5% 
CO2. 
 
Mice and primary mouse embryonic fibroblasts. Mice 
lacking part of the helicase domain of the Wrn gene 
were generated by homologous recombination as 
previously described [32]. In the process, 121 amino 
acid residues of the Wrn protein were deleted (amino 
acids 710 to 831; Wrn
Δhel).  Wrn
Δhel/Δhel homozygous 
animals were backcrossed onto the pure C57BL/6 
genetic background (Harlan Laboratories, Indianapolis, 
IN) for twelve generations. Safb1-null mice were also 
generated by homologous recombination and had a 
deletion of exons 7 through 22 [26]. The genetic 
background of these mice was on a mixed C57BL/6J-
129/Sv background.  Mice of all possible genotypes 
were generated by mating homozygous Wrn
Δhel/Δhel 
individuals with Safb1-null mice and inter-crossing the 
F1 and F2 generations to obtain all four desired 
genotypes. Genotyping was performed by Southern 
blotting with appropriate probes [26, 32]. Mice were 
housed in cages (containing a top filter) on static racks 
in a conventional animal facility at 22
+2°C with 40-50% 
humidity and a 12h light-dark cycle (light cycle: 06:00-
18:00h). All mice were fed ad libitum with Teklad 
Global (Madison, WI) 18% protein rodent diet (5% fat). 
Care of mice was in accordance with the guidelines of 
the Committee for the protection of animals at the 
University Laval. Animals were checked every day for 
any external mass, infection, bleeding, gasping, and 
overall decrease or change in activity or behavior. Mice 
that became immobile or moribund were sacrificed for 
histological examination of their organs as described 
previously [30].  
 
The generation and maintenance of mouse embryonic 
fibroblasts have been described previously [30]. Briefly, 
healthy 14-day old embryos were minced in 6-well 
plates and maintained in low glucose DMEM 
supplemented with 10% heat inactivated calf serum at 
37◦C in an atmosphere of 5% CO2. Adherent cells 
established from embryonic tissues were passaged as 
soon as they reached confluence. Cell proliferation was 
determined by plating 5x10
4 cells in six-well plates. The 
cultures were maintained for up to 11 days with 
changing media every other day. Cells were counted on 
a hemacytometer. The R software version 2.10.1 
(http://www.r-project.org/) was used to estimate the 
growth rate and the associated standard error. Briefly, 
the logarithm in base 10 was taken from the cell count 
prior to fitting a linear model of the form log10(cell 
count) = log10(50 000) + K*x, where K represents the 
growth rate and x the day. 
 
Senescence associated β-galactosidase staining. 
Senescence-associated  β-galactosidase was used as a 
marker of senescence and cells were stained for this 
marker as described [48]. The percentage of blue β-
galactosidase positive cells was determined by counting 
at least 200 cells (inverted microscope Nikon TMS). 
 
Lung histology. Lungs from live 19 days old embryos 
were fixed in 4% paraformaldehyde and embedded in 
paraffin. Thin sections were mounted on glass slides 
and stained with hematoxilin/eosin. TUNEL assays 
were performed on lung tissue sections for the detection 
of apoptotic cells using an In situ Apoptosis Detection 
Kit (R&D Systems, Minneapolis, MN) following the 
manufacturer’s recommendations. Positive cells were 
counted and photographed. Digital images of tissues 
were captured using a Leica microscope equipped with 
a Dage-MTI CCD camera (Mutech Corp., Billerica, 
MA). To estimate cell proliferation in lung tissues, 
standard immunohistochemistry with a mouse 
monoclonal antibody against PCNA (Santa Cruz 
Biotechnology, Santa Cruz, CA) was performed on the 
   
www.impactaging.com                   287                                        AGING, March 2011, Vol.3 No.3paraffin sections. PCNA positive cells were revealed 
with diaminobenzidine (DAB).  
 
Indirect immunofluorescence.  Mouse embryonic 
fibroblasts were grown on glass coverslips for 24 hours, 
fixed in cold methanol for 10 min, permeabilized with 
0.15% Triton X-100 at 4°C for 10 min, washed with 
PBS, and blocked with 2% milk at 4°C for 30 min. An 
anti- γ-H2AX monoclonal antibody (Upstate, Lake 
Placid, NY) diluted in blocking buffer was applied and 
incubated overnight at 4°C. Coverslips were washed 
with PBS and incubated with rhodamine-secondary 
antibody for one hour at room temperature 
(AmershamPharmacia, Piscataway, NJ). After washing, 
coverslips were mounted on glass slides and viewed at 
60 X magnification on a Nikon inverted diaphot 
confocal microscope. Images were captured with a 
BioRad MRC1024 confocal microscopy system and 
then colored Adobe Photoshop to allow counting the 
number of foci/cell nucleus. 
 
Immunoprecipitations and Western blot analysis. Mouse 
embryonic fibroblasts were lysed in RIPA buffer (50 
mM Tris HCl (pH 7.5), 150 mM NaCl, 1% NP-40, 
0.1% SDS, 0.5% deoxycholate) for immuno-
precipitation and Western blot analyses. A goat 
polyclonal antibody against WRN (C-19) (Santa Cruz 
Biotechnology, Santa Cruz, CA) was used for 
immunoprecipitation and a rabbit polyclonal anti-WRN 
antibody from US Biologicals (Cleveland, OH) was 
used for the immunoblots. Rabbit polyclonal antibodies 
against the phsophorylated and unphosphorylated forms 
of the p38 MAP kinase were purchased from Cell 
Signaling Technology (Danvers, MA). A rabbit 
polyclonal antibody against JNK1 was purchased from 
AbCam (Cambridge, MA). A mouse monoclonal 
antibody against SAFB1 was purchased from Upstate 
Biotechnology (Lake Placid, NY). A horseradish 
peroxidase conjugated anti-p53 antibody (DO-1), a rat 
monoclonal antibody against p19(Arf), and a rabbit 
polyclonal antibody against PKCδ were purchased from 
Santa Cruz Biotechnology (Santa Cruz, CA). A rabbit 
polyclonal antibody against p21(Waf1) was purchased 
from Oncogene Research Products (Boston, MA). 
Horseradish peroxidase conjugated secondary 
antibodies and ECL reagents were from Amersham 
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Figure  S1.  A  seven  weeks  old  Safb1
‐/‐/Wrn
∆hel/∆hel  double 








∆hel/∆hel  mouse  in  the  middle  and  right 
panels.  Alopecia  in  a  double  homozygous  mutant  mouse  is 
visible on the photograph (left panel). 
 
Figure S2. Protein levels of p21 in MEFs. Longer exposition (3
min with ECL reagents) of the p21 Western blot in figure 8. β‐
tubulin was used as a loading control. 